Article Details

GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination ...

Retrieved on: 2021-10-21 09:23:16

Tags for this article:

Click the tags to see associated articles and topics

GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination .... View article details on HISWAI: https://www.wwnytv.com/prnewswire/2021/10/21/genfleet-announces-first-patient-dosed-phase-ibii-trial-tgf-r1-inhibitor-combination-with-pd-1-inhibitor-global-multi-center-research/

Excerpt

Compared to antibodies targeting the TGF-β pathway, GFH018 as a small ... Toripalimab is an anti-PD-1 monoclonal antibody developed by Junshi ...

Article found on: www.wwnytv.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up